LaFerla F - Search Results

1

In vivo optical signatures of neuronal death in a mouse model of Alzheimer's disease.

Lin AJ, Castello NA, Lee G, Green KN, Durkin AJ, Choi B, LaFerla F, Tromberg BJ. Lin AJ, et al. Among authors: laferla f. Lasers Surg Med. 2014 Jan;46(1):27-33. doi: 10.1002/lsm.22206. Epub 2013 Nov 28. Lasers Surg Med. 2014. PMID: 24284732 Free PMC article.

2

Presenilin regulates capacitative calcium entry dependently and independently of gamma-secretase activity.

Akbari Y, Hitt BD, Murphy MP, Dagher NN, Tseng BP, Green KN, Golde TE, LaFerla FM. Akbari Y, et al. Biochem Biophys Res Commun. 2004 Oct 1;322(4):1145-52. doi: 10.1016/j.bbrc.2004.07.136. Biochem Biophys Res Commun. 2004. PMID: 15336962

3

Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease.

Oddo S, Caccamo A, Green KN, Liang K, Tran L, Chen Y, Leslie FM, LaFerla FM. Oddo S, et al. Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):3046-51. doi: 10.1073/pnas.0408500102. Epub 2005 Feb 10. Proc Natl Acad Sci U S A. 2005. PMID: 15705720 Free PMC article.

4

Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice.

Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM. Billings LM, et al. Neuron. 2005 Mar 3;45(5):675-88. doi: 10.1016/j.neuron.2005.01.040. Neuron. 2005. PMID: 15748844 Free article.

5

Calcium dysregulation in Alzheimer's disease: recent advances gained from genetically modified animals.

Smith IF, Green KN, LaFerla FM. Smith IF, et al. Among authors: laferla fm. Cell Calcium. 2005 Sep-Oct;38(3-4):427-37. doi: 10.1016/j.ceca.2005.06.021. Cell Calcium. 2005. PMID: 16125228 Review.

6

Enhanced caffeine-induced Ca2+ release in the 3xTg-AD mouse model of Alzheimer's disease.

Smith IF, Hitt B, Green KN, Oddo S, LaFerla FM. Smith IF, et al. Among authors: laferla fm. J Neurochem. 2005 Sep;94(6):1711-8. doi: 10.1111/j.1471-4159.2005.03332.x. J Neurochem. 2005. PMID: 16156741 Free article.

7

Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease.

Kitazawa M, Oddo S, Yamasaki TR, Green KN, LaFerla FM. Kitazawa M, et al. J Neurosci. 2005 Sep 28;25(39):8843-53. doi: 10.1523/JNEUROSCI.2868-05.2005. J Neurosci. 2005. PMID: 16192374 Free PMC article.

8

Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology.

Oddo S, Caccamo A, Tran L, Lambert MP, Glabe CG, Klein WL, LaFerla FM. Oddo S, et al. J Biol Chem. 2006 Jan 20;281(3):1599-604. doi: 10.1074/jbc.M507892200. Epub 2005 Nov 10. J Biol Chem. 2006. PMID: 16282321 Free article.

9

A dynamic relationship between intracellular and extracellular pools of Abeta.

Oddo S, Caccamo A, Smith IF, Green KN, LaFerla FM. Oddo S, et al. Among authors: laferla fm. Am J Pathol. 2006 Jan;168(1):184-94. doi: 10.2353/ajpath.2006.050593. Am J Pathol. 2006. PMID: 16400022 Free PMC article.

10

M1 receptors play a central role in modulating AD-like pathology in transgenic mice.

Caccamo A, Oddo S, Billings LM, Green KN, Martinez-Coria H, Fisher A, LaFerla FM. Caccamo A, et al. Neuron. 2006 Mar 2;49(5):671-82. doi: 10.1016/j.neuron.2006.01.020. Neuron. 2006. PMID: 16504943 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

280 results

Search Page

Filters